Iku Abe
Saitama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Giant esophageal schwannoma mimicking a mediastinal tumor: a case report and review of the literature.
Journal: International journal of surgery case reports
Published: March 17, 2026
DNA Hypomethylation in Pancreatic Cancer Tissues Before Treatment, Defined by KRAS -mutated Circulating Tumor DNA, is Associated With Poor Prognosis.
Journal: Pancreas
Published: January 28, 2025
Real-time assessment of circulating tumor cells refines the indication for HER2-targeted therapy in metastatic gastric cancer.
Journal: Scientific reports
Published: November 05, 2024
A postoperative body weight increase is a novel risk factor for incisional hernia of midline abdominal incision after elective gastroenterological surgery.
Journal: Langenbeck's archives of surgery
Published: October 06, 2023
Efficacy of ramucirumab and subsequent nivolumab therapy in patients with advanced gastric cancer: A retrospective study.
Journal: Molecular and clinical oncology
Published: July 21, 2023
Minimally invasive esophagectomy in the semi-prone position for corrosive esophagitis: a case report.
Journal: Journal of surgical case reports
Published: March 17, 2022
Overexpression of satellite RNAs in heterochromatin induces chromosomal instability and reflects drug sensitivity in mouse cancer cells.
Journal: Scientific reports
Published: January 06, 2022
Enhancement of DNA hypomethylation alterations by gastric and bile acids promotes chromosomal instability in Barrett's epithelial cell line.
Journal: Scientific reports
Published: January 05, 2022
Genome‑wide DNA hypomethylation drives a more invasive pancreatic cancer phenotype and has predictive occult distant metastasis and prognosis potential.
Journal: International journal of oncology
Published: January 01, 2022
Prophylactic use of pegfilgrastim enables the management of severe neutropenia without dose delays in patients with metastatic colorectal cancer treated with TAS-102 plus bevacizumab.
Journal: Molecular and clinical oncology
Published: July 11, 2021
Optimal value of CA19-9 determined by KRAS-mutated circulating tumor DNA contributes to the prediction of prognosis in pancreatic cancer patients.
Journal: Scientific reports
Published: May 28, 2021
Last Updated: 09/26/2026